Derrell Porter
Director/Board Member at PASSAGE BIO, INC.
Net worth: - $ as of 2024-04-29
Profile
Dr. Derrell D.
Porter is a Chief Executive Officer at CTRL Therapeutics, Inc., an Independent Director at Acumen Pharmaceuticals, Inc. and an Independent Director at Passage Bio, Inc. He is on the Board of Directors at Acumen Pharmaceuticals, Inc., Passage Bio, Inc., Biosortia Pharmaceuticals, Inc. and Portal Innovations LLC.
Dr. Porter was previously employed as a Chief Executive Officer by Cellevolve Bio, a Senior Vice President & Global Head-Commercial by Atara Biotherapeutics, Inc., a Vice President by Gilead Sciences, Inc., a Sales Manager & Director-Corporate Development by AbbVie, Inc., and a Director-Corporate Development & Sales Manager by Amgen, Inc. He also served on the board at Alliance for Regenerative Medicine.
He received his undergraduate degree from the University of California, Los Angeles, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from Perelman School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-07 | 0 ( -.--% ) | - $ | 2024-04-29 | |
PASSAGE BIO, INC.
-.--% | 2024-05-20 | 0 ( -.--% ) | - $ | 2024-04-29 |
Derrell Porter active positions
| Companies | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Director/Board Member | 2021-05-26 |
| ACUMEN PHARMACEUTICALS, INC. | Director/Board Member | 2023-01-03 |
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Director/Board Member | - |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Director/Board Member | - |
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Chief Executive Officer | 2023-04-30 |
Former positions of Derrell Porter
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2019-09-30 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2017-04-30 |
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Chief Executive Officer | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | - |
| ░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Training of Derrell Porter
| University of California, Los Angeles | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| AMGEN INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
Cellevolve Bio
Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Derrell Porter
